New U.S. Department of Defense Research Collaboration with Immuron to Develop and Clinically evaluate a New Therapeutic against Campylobacter

Ads

You May Also Like

Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair

LOS ANGELES, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (“Enochian”) a biopharmaceutical ...

Aravive Reports Third Quarter 2018 Financial Results and Provides Company Updates

- Merger completed; now operating as Aravive, Inc. (Nasdaq:ARAV), a clinical-stage biopharmaceutical company advancing ...